Patient Square Capital »

Intra Cellular Therapies shares owned by Patient Square Capital

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Patient Square Capital from 13F filings

Historical chart of Patient Square Capital investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Patient Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Patient Square Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.0M 72k 83.52

More positions owned by Patient Square Capital

Roivant Sciences SHS (ROIV)
Insmed Com Par $.01 (INSM)
Eyepoint Pharmaceuticals Com New (EYPT)
Abivax Sa Sponsored Ads (ABVX)
Cidara Therapeutics Com New (CDTX)
Argenx Se Sponsored Adr (ARGX)
Liquidia Corporation Com New (LQDA)
Pharvaris N V (PHVS)
Ocular Therapeutix (OCUL)
Mirum Pharmaceuticals (MIRM)
Agios Pharmaceuticals (AGIO)
Kymera Therapeutics (KYMR)
Enliven Therapeutics (ELVN)
Celcuity (CELC)
Dianthus Therapeutics (DNTH)

View all positions for Patient Square Capital

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies